Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Individual Dosage Selection of Irinotecan (CPT-11) Based on UGT1A1 Genotype in Metastatic Colorectal Cancer Patients

This study has been completed.
Information provided by (Responsible Party):
Xu jianming, The Affiliated Hospital of the Chinese Academy of Military Medical Sciences Identifier:
First received: January 19, 2012
Last updated: March 29, 2017
Last verified: March 2017
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 27, 2016
  Primary Completion Date: November 23, 2015 (Final data collection date for primary outcome measure)